David Renzi
Overview
David Renzi received an average of $1M in total compensation, including $382K in salary, at Carbylan Therapeutics between 2014 and 2015.
Source: SEC filing on April 28, 2016.
Related executives
We found six more executives who work or worked at Carbylan Therapeutics.
T Crockett
Carbylan Therapeutics
Chief Executive Officer
Benjamin Palleiko
Carbylan Therapeutics
Chief Financial Officer
Christopher Yea
Carbylan Therapeutics
Chief Development Officer
Edward Feener
Carbylan Therapeutics
Chief Scientific Officer
Premchandran Ramiya
Carbylan Therapeutics
Vice President, Pharmaceutical Development & Supply Chain
Marcee Maroney
Carbylan Therapeutics